NIH begins clinical trial of investigational vaccine for COVID-19
March 19, 2020
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding a Phase 1 clinical trial at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. KPWHRI is part of NIAID’s Infectious Diseases Clinical Research Consortium. Learn More.